<?xml version="1.0"?>

<document>
	<title>Normal plasma arginine esterase and the Hageman factor (factor XII)
   -prekallikrein-kininogen system in cystic fibrosis.</title>

	<author>Goldsmith-G-H.</author>
	<author>Stern-R-C.</author>
	<author>Saito-H.</author>
	<author>Ratnoff-O-D.</author>

	<source>J-Lab-Clin-Med. 1977 Jan. 89(1). P 131-4.</source>

	<abstract>Previous investigators have suggested that the biological activity of
   plasma prekallikrein is defective in cystic fibrosis. In contrast, no
   such difference was demonstrable between normal and cystic fibrosis
   plasma. Esterolytic activity for the synthetic substrate p-toluene
   sulfonyl-arginine methyl ester (TAMe) evolved normally in cystic
   fibrosis plasma treated with chloroform and ellagic acid, a measure
   of generation of plasma kallikrein. Additionally, plasma
   prekallikrein (Fletcher factor) and high molecular weight kininogen
   (Fitzgerald factor), a substrate of plasma kallikrein, were normal.
   Thus, the concept that cystic fibrosis is associated with
   abnormalities in the plasma kallikrein-kinin system could not be
   supported.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: bl</majorsubject>
	<majorsubject>ESTERASES: bl</majorsubject>
	<majorsubject>FACTOR-XII</majorsubject>
	<majorsubject>KALLIKREIN</majorsubject>
	<majorsubject>KININOGENS: bl</majorsubject>
	<majorsubject>PREKALLIKREIN</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>ARGININE</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>TOSYLARGININE-METHYL-ESTER: me</minorsubject>
	<minorsubject>SUPPORT-U-S-GOVT-P-H-S</minorsubject>

	<reference>001   MANGOS JA             PEDIATR RES                      2   378 968</reference>
	<reference>002   RAO GJS               J PEDIATR                       80   573 972</reference>
	<reference>003   SPOCK A               PEDIATR RES                      1   173 967</reference>
	<reference>004   BOWMAN BH             SCIENCE                        164   325 969</reference>
	<reference>005   RAO GJS               SCIENCE                        177   610 972</reference>
	<reference>006   RAO GJS               PEDIATR RES                      8   684 974</reference>
	<reference>007   LIEBERMAN J           AM REV RESPIR DIS              109   399 974</reference>
	<reference>008   SIEGELMAN AM          ARCH BIOCHEM BIOPHYS            97   159 962</reference>
	<reference>010   ZIMMERMAN TS          J CLIN INVEST                   50   244 971</reference>
	<reference>011   SAITO H               J CLIN INVEST                   55  1082 975</reference>
	<reference>012   COLMAN RW             J CLIN INVEST                   48    23 969</reference>
	<reference>013   DONALDSON VH          CIRC RES                        34   652 974</reference>
	<reference>014   OH-ISHI S             BIOCHEM PHARMACOL               24   591 975</reference>
	<reference>015   COBURN MD             AM REV RESPIR DIS              110   368 974</reference>
	<reference>016   TALAMO RC             PEDIATR RES                      6   430 972</reference>
	<reference>017   RAO GJS               PEDIATR RES                      9   739 975</reference>
	<reference>018   WILSON GB             PEDIATR RES                     10    87 976</reference>


</document>
